VisMederi Holding

Improving human health

VISMEDERI TEXTYLE SRL

Qualified Centre capable of carrying out all the main analyses necessary to certify the quality of textile materials, as well as the conformity and quality of raw materials and semi-finished products in the tanning sector with the verification of CITES certificates through DNA analysis.

www.vismederitextyle.com

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

tttt

tttt

ttt

Vismederi Group

The Group of Vismederi Holding operates in various business areas all related to Research and Innovation in the fields of Public Health, Life Sciences and Biotechnologies and is composed of VisMederi Srl, VisMederi Research Srl, VisMederi Life Sciences Srl, VisMederi Textyle Srl, VisMederi Pharma Srl, ETHS – Education and Training for Health Sciences Srl with single shareholder, Srl.

Vismederi Holding

VisMederi is today a solid reality that grew year after year in credibility, customer portfolio, human resources and economic results. These are the results of prolific work carried out by a motivated, young and highly competent group, which has found in VisMederi not only a job but also a great opportunity for professional growth.

0Mln €

Revenues

0

Employees 

0Paesi

Global Partnerships

Vismederi Holding: last news

All the news of the group

Dec 05 2025

New scientific publication: “High-dose influenza vaccine: enhanced protection for the elderly”

A new scientific paper authored by Emanuele Montomoli and Claudia Maria Trombetta has just been published in Expert Review of Vaccines: “High-dose...
Dec 03 2025

VisMederi America: a new chapter in the Group’s international growth

VisMederi is pleased to announce the establishment of VisMederi America, a new company based in Cleveland that marks a strategic milestone in the...
Nov 27 2025

VisMederi in the Sole 24 Ore ranking: recognized growth and international development

VisMederi is once again included in the "Leader of Growth 2026" ranking compiled by Il Sole 24 Ore in collaboration with Statista, where it ranks...
Nov 03 2025

Development and Qualification of the Shigella Multiplex Assay: New Publication Highlights Major Collaborative Milestone

A new milestone in bacterial vaccine research: after several years of intensive research, validation work, and cross-institutional collaboration,...
Oct 23 2025

VisMederi contributes to Clover Biopharmaceuticals’ advancement in innovative respiratory combination vaccines

We are proud to be part of Clover Biopharmaceuticals’ important achievement in advancing innovative respiratory combination vaccines. VisMederi...
Oct 22 2025

VisMederi at the 10th ESWI Influenza Conference in Valencia

VisMederi continues to strengthen its engagement in metapneumovirus control and vaccine research, confirming its active role in the international...
Oct 17 2025

Inspiring and productive week at the World Vaccine Congress Europe 2025 in Amsterdam

Our team wrapped up an inspiring and productive week at the World Vaccine Congress Europe 2025 in Amsterdam — the leading European event dedicated...
Oct 16 2025

Project Director Luisa Ganfini was invited by Osivax and ClinChoice to Verona to participate in the recent Investigator Meetin

During the event, Luisa presented the key role that VisMederi will play in the upcoming Phase 2b clinical study. The meeting provided a valuable...
Oct 16 2025

VisMederi’s Cell Mediated Immunity Team members in Sofia to deliver a training session at Hera Medical Center

VisMederi's Cell Mediated Immunity (CMI) Team members, Ilaria Razzano and Ilaria Ferrigno, traveled to Sofia to deliver a training session at Hera...
Aug 05 2025

New paper on the use of pseudotyped viral vectors to study the antibody-mediated immune responses

A new paper from our team is online. The paper dissects the use of pseudotyped viral vectors to study the antibody-mediated immune responses. The...

Where we

are

 

 

 

 

 

 

The

founder

Emanuele Montomoli is Full Professor of Hygiene and Public Health at the University of Siena, Italy. He received his BSc and MSc in Life Sciences from the University of Siena, Italy in 1997 and he earned his MBiochem in 2001.

[custom-facebook-feed feed=2]